(Reuters) -An investment consortium, comprising of Elliott Investment Management, Patient Square Capital and Veritas Capital, has agreed to take Syneos Health Inc private for $4.46 billion, the contract research firm said on Wednesday. Shares of Syneos rose 8.7% to $41.8 in early trade. The consortium will pay about $43 per share in cash, which represents…
By Ludwig Burger FRANKFURT (Reuters) – Zealand Pharma and partner Boehringer Ingelheim said their experimental obesity drug achieved up to 14.9% weight loss after 46 weeks in a mid-stage trial, adding a potential contestant to the fast growing obesity drug market. In a statement on Wednesday, the partners said that the Phase II dose-finding trial…
By Summer Zhen HONG KONG (Reuters) – People in China splashed out on dining, travel and luxury goods after emerging from three years of pandemic restrictions but are still not spending freely on routine consumer items, if first quarter corporate results are an indication. There was a broad bounce in earnings after China ended its…
SHANGHAI/SINGAPORE (Reuters) – A fresh wave of COVID-19 is spreading through China as people return from public holiday travel, reaching trading floors and raising concern of an impact to trading volume – albeit likely not as pronounced as previous pandemic-induced disruption. More than half a dozen traders and banking sources told Reuters this week that…
By Anirban Sen NEW YORK (Reuters) -A consortium comprising Elliott Investment Management, Patient Square Capital and Veritas Capital is nearing a deal to acquire Syneos Health Inc, a provider of clinical research to drug developers, for more than $7 billion, including debt, people familiar with the matter said. The consortium will pay about $43 per…
By David Shepardson WASHINGTON (Reuters) – President Joe Biden on Tuesday revoked requirements that most international visitors to the United States be vaccinated against COVID-19 as well as similar rules for federal employees and contractors. Biden’s orders take effect at 12:01 a.m. ET May 12 with the expiration of the U.S. COVID public health emergency….
By Nancy Lapid (Reuters) -Women at average risk for breast cancer should get screening mammograms every other year starting at age 40, according to a proposed guideline update from the U.S. Preventive Services Task Force (USPSTF), reflecting improved diagnostic technology and treatment. The update reverses a controversial recommendation made by the panel in 2009, when…
By Bhanvi Satija and Michael Erman (Reuters) -COVID-19 vaccine maker Novavax Inc on Tuesday forecast much higher 2023 revenue than Wall Street expected and announced plans to cut a quarter of its workforce, spurring hopes of a recovery for the cash-strapped biotech, and its shares jumped 40%. In February, the company raised doubts about its…
By Patrick Wingrove and Michael Erman (Reuters) – Some of the world’s biggest drugmakers are laying legal groundwork to fight the U.S. plan to negotiate drug prices for its Medicare health coverage, including the argument that a ban against speaking about these talks violates constitutional rights, according to six industry sources. The Biden Administration’s signature…
By Rachael Levy and Marisa Taylor (Reuters) – Elon Musk’s brain-implant venture has filled an animal-research oversight board with company insiders who may stand to benefit financially as the firm reaches development goals, according to company documents and interviews with six current and former employees. Such oversight boards are required by federal law for organizations…
